Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -230.05% is in line with its 5-year average of -246.26%, near the high end of its 5-year range (-986.41%–-66.16%).
As of the fiscal period ended Tuesday, June 30, 2026. 19.66% above its 12-month average of -286.33%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -230.05%.
RETURN ON EQUITY (ROE)
-230.05%
RETURN ON EQUITY (ROE) AVG TTM
-286.33%
RETURN ON EQUITY (ROE) AVG 3Y
-274.25%
RETURN ON EQUITY (ROE) AVG 5Y
-246.26%
RETURN ON EQUITY (ROE) AVG 10Y
-190.39%
RETURN ON EQUITY (ROE) AVG 15Y
N/A
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
+19.66%
CURRENT VS 3Y AVG
+16.12%
CURRENT VS 5Y AVG
+6.58%
CURRENT VS 10Y AVG
-20.83%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-28.46%
median of 339 covered companies
CURRENT VS SECTOR MEDIAN
-708.34%
vs the sector median at left
Axsome Therapeutics, Inc.
Market Cap
$9.11B
Return on Equity (ROE)
-230.05%
TTM Avg
-286.33%
3Y Avg
-274.25%
5Y Avg
-246.26%
Market Cap
$9.35B
Return on Equity (ROE)
-2.97%
TTM Avg
3.00%
3Y Avg
15.91%
5Y Avg
17.66%
Market Cap
$9.39B
Return on Equity (ROE)
26.39%
TTM Avg
25.41%
3Y Avg
19.99%
5Y Avg
14.02%
Market Cap
$8.78B
Return on Equity (ROE)
-68.73%
TTM Avg
-161.81%
3Y Avg
-110.86%
5Y Avg
-82.70%
Market Cap
$9.60B
Return on Equity (ROE)
12.77%
TTM Avg
11.88%
3Y Avg
12.69%
5Y Avg
13.50%
Market Cap
$8.59B
Return on Equity (ROE)
17.77%
TTM Avg
-40.95%
3Y Avg
-11.78%
5Y Avg
-8.64%
Market Cap
$9.72B
Return on Equity (ROE)
-2.97%
TTM Avg
3.00%
3Y Avg
15.91%
5Y Avg
17.66%
Market Cap
$8.41B
Return on Equity (ROE)
26.84%
TTM Avg
-21.41%
3Y Avg
-36.14%
5Y Avg
-25.75%
Market Cap
$10.07B
Return on Equity (ROE)
9.77%
TTM Avg
10.54%
3Y Avg
10.84%
5Y Avg
19.93%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Axsome Therapeutics, Inc. (AXSM) | $9.11B | -230.05% | -286.33% | -274.25% | -246.26% |
| Bruker Corporation (BRKRP)vs › | $9.35B | -2.97% | 3.00% | 15.91% | 17.66% |
| Insulet Corp. (PODD)vs › | $9.39B | 26.39% | 25.41% | 19.99% | 14.02% |
| Arrowhead Pharmaceuticals, Inc. (ARWR)vs › | $8.78B | -68.73% | -161.81% | -110.86% | -82.70% |
| Henry Schein, Inc. (HSIC)vs › | $9.60B | 12.77% | 11.88% | 12.69% | 13.50% |
| Caris Life Sciences, Inc. (CAI)vs › | $8.59B | 17.77% | -40.95% | -11.78% | -8.64% |
| Bruker Corporation (BRKR)vs › | $9.72B | -2.97% | 3.00% | 15.91% | 17.66% |
| Oscar Health, Inc. (OSCR)vs › | $8.41B | 26.84% | -21.41% | -36.14% | -25.75% |
| Align Technology, Inc. (ALGN)vs › | $10.07B | 9.77% | 10.54% | 10.84% | 19.93% |
| The Ensign Group, Inc. (ENSG)vs › | $10.08B | 15.51% | 15.81% | 15.92% | 17.27% |
ROE
-230.1%
ROA
-25.2%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -230.05% |
| 2026-03-31 | -344.96% |
| 2025-12-31 | -207.46% |
| 2025-09-30 | -311.32% |
| 2025-06-30 | -337.87% |
| 2025-03-31 | -523.02% |
| 2024-12-31 | -503.76% |
| 2024-09-30 | -334.73% |
| 2024-06-30 | -300.00% |
| 2024-03-31 | -205.77% |
| 2023-12-31 | -125.27% |
| 2023-09-30 | -74.89% |
| 2023-06-30 | -66.16% |
| 2023-03-31 | -141.95% |
| 2022-12-31 | -170.81% |
| 2022-09-30 | -101.59% |
| 2022-06-30 | -986.41% |
| 2022-03-31 | -957.78% |
| 2021-12-31 | -834.29% |
| 2021-09-30 | -294.00% |
| 2021-06-30 | -159.07% |
| 2021-03-31 | -103.51% |
| 2020-12-31 | -90.43% |
| 2020-09-30 | -72.85% |
| 2020-06-30 | -61.43% |
| 2020-03-31 | -57.76% |
| 2019-12-31 | -38.24% |
| 2019-09-30 | -778.81% |
| 2019-06-30 | -174.12% |
| 2019-03-31 | -211.82% |
| 2018-06-30 | -384.52% |
| 2018-03-31 | -204.62% |
| 2017-12-31 | -173.14% |
| 2017-09-30 | -171.28% |
| 2017-06-30 | -130.10% |
| 2017-03-31 | -100.17% |
| 2016-12-31 | -126.10% |
| 2016-09-30 | -76.59% |
| 2016-06-30 | -54.34% |
| 2016-03-31 | -34.64% |
| 2015-12-31 | -22.74% |
| 2015-09-30 | -264.75% |
